MATERIAL EVENT4577.TTSE

Daito Pharmaceutical: change in major shareholder

Summary

Daito Pharmaceutical Co., Ltd. filed an extraordinary report via EDINET on 2024-08-28 16:43 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100UAL8 ↗ · PDL1.0 · Not investment advice